C26H29N5O3S
491.6 g/mol
APIWarning
Grapiprant
CAS415903-37-6
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Grapiprant is a veterinary non-steroidal anti-inflammatory drug from the piprant class, developed as a prostaglandin receptor antagonist. It was approved in March 2016 by the FDA's Center for Veterinary Medicine as a non-cyclooxygenase inhibiting NSAID for veterinary use.
pharmaceutical raw material for veterinary anti-inflammatory formulationscompound used in veterinary pharmaceutical manufacturing
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 415903-37-6
Related Compounds
ReferenceSame Category
Ciclopirox olamine
CAS41621-49-2
pharmaceutical raw material
ReferenceSame Category
Ginsenoside Rb1
CAS41753-43-9
pharmaceutical raw material
ReferenceSame Category
Trepibutone
CAS41826-92-0
pharmaceutical raw material
ReferenceSame Category
Bezafibrate
CAS41859-67-0
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea
InChIKey
HZVLFTCYCLXTGV-UHFFFAOYSA-N
SMILES
CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C
Synonyms (18)
- A1ECR
- Grapiprant (USAN/INN)
- CJ-023,423
- CJ-023423;RQ-00000007;AAT-007
- Galliprant
- Grapiprant
- Grapiprant (CJ-023423)
- grapiprantum